Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check27 days agoChange DetectedUpdated the site’s version tag from v3.0.2 to v3.1.0, signaling a new release. No changes to core content, pricing, or availability are evident.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the 'Back to Top' element has been removed.SummaryDifference0.2%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in South Korea, as well as new medical topics related to colorectal and intestinal diseases. Notably, the drug vactosertib has been included, while previous references to Pembrolizumab and various cancer-related topics have been removed.SummaryDifference3%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.